Sector portfolio · Private equity · United States
Frazier Healthcare Partners' Biotech portfolio
Frazier Healthcare Partners has backed 25 Biotech startups in rounds we track, $3.3B between them, shown by the stage each has reached. The best-funded is Phathom Pharmaceuticals.
25startups backed
4stages
$3.3Braised between them
Series C and laterbiggest stage
Funding by segment
- Series C and later$1.1B8
- Series B$1.2B7
- Stage not reported$856M6
- Series A$100M4
Where they are based
- United States25$3.3B
United StatesFounded
15Earlier
212
113
14
215
316
17
218
19
20
21
22
23
24
25
26
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M8
- $50M to $250M12
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
25 of 25 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States25
Startups by country, 1 country in all.
Segment by segment
Series C and later
8 startups · $1.1B raised
CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M- SSutroVaxUnited States$167M
MoximedMoximed Inc.United States$146M- PPowerVisionPowerVision is a device company developing implantable intraocular lenses.United States$108M
- CPCalistoga PharmaceuticalsCalistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases.United States$97M
AnaptysBioAnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing United States$85M- CMCalibra MedicalCalibra is a medical device company developing a wearable three-day insulin patch designed to treat diabetics.United States$55M
- SSojournixSojournix is a clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of neuroendUnited States$44M
Series B
7 startups · $1.2B raised
- CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
Cardiac DimensionsCardiac Dimensions is a medical device company based in Kirkland, Washington, founded in 2001.United States$150M
AptinyxAptinyx Inc.United States$76M- IBImago BioSciencesImago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.United States$67M
Scout BioScout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.United States$53M
Allena PharmaceuticalsAllena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.United States$43M
Stage not reported
6 startups · $856M raised
Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530MEBR SystemsEBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.United States$161M
- TPTrubion PharmaceuticalsTrubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.United States$56M
- ATAltiris TherapeuticsAltiris Therapeutics develops and commercializes drugs to treat metastatic cancer.United States$44M
- LPLaguna PharmaceuticalsLaguna Pharmaceuticals focuses on the development of vanoxerine derivative for the treatment of atrial fibrillation and atrial flutter.United States$36M
AlcrestaAlcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.United States$30M
Series A
4 startups · $100M raised
- CTCirius TherapeuticsUnited States$40M
- ATArete TherapeuticsArete Therapeutics is a pharmaceutical company that develops small molecule therapeutics for diabetes and cardiovascular disease.United States$35M
Marcadia BiotechMarcadia Biotech is focused on developing therapeutic products to improve the daily life of people with diabetes and obesity.United States$16M- RTRecida TherapeuticsUnited States$8.5M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Frazier Healthcare Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCo-investorsWho invests with Frazier Healthcare Partners33 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8BSector portfolioGaingels' AI portfolio146 startups · $14BSector portfolioCormorant Asset Management's Biotech portfolio95 startups · $21B
Raising from investors like Frazier Healthcare Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.